Remove category legal-regulatory
article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Cannabinoid receptors fall into two categories: CB1 and CB2 receptors. Despite the current popularity of cannabinoid receptors, the regulatory landscape is challenging and complex. In the US, the world’s largest pharmaceutical market, most states have legalized cannabinoids for medical use.

article thumbnail

FDA Finalizes Guidance Re Enforcement Policy for Homeopathic Drugs

The FDA Law Blog

As we reported previously, here , and here , as a result of the growth of the industry and safety issues, in 2015 FDA started the reevaluation of its regulatory framework for homeopathic products. This concludes FDA’s reevaluation of the regulation of homeopathic drugs which it started in 2015.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Hyman, Phelps & McNamara, P.C. Takes Top Honors in Two Prestigious Categories in 2023 LMG Life Sciences Awards

The FDA Law Blog

is pleased to announce it took top honors in two categories in the 2023 LMG Life Sciences Awards, which recognize the best life science practitioners and firms over the past 12 months from the United States, Canada, and Europe. The firm’s clients are as diverse as the regulatory issues they face. life sciences industry.

article thumbnail

Hazardous Drug Compliance

DiversifyRx

Hazardous drugs constitute a distinct category of pharmaceuticals that demand special attention from all types of pharmacies, not just compounding. Importance of Compliance Compliance with regulations pertaining to hazardous drugs is not merely a matter of legal obligation; it is an ethical and safety imperative.

article thumbnail

Four things you need to know about FDA regulations and digital health

pharmaphorum

Devices, like pharmaceuticals, are divided into risk categories with heavier or lighter regulation depending on the risk to the patient. You have a pacemaker on one end and a tongue depressor on the other, and then FDA has to figure out a regulatory scheme that takes into account every one of them, again, without stifling innovation.”.

FDA 133
article thumbnail

Building Resilient and Sustainable Pharmaceutical Supply Chains

ISPE

Regulatory efforts aim to improve planning and preventative measures, while some governments have implemented legislative measures encouraging onshoring as a protective measure to insulate domestic supply chains from disruption.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

Postapproval change management of pharmaceuticals is an essential part of life-cycle management but is associated with regulatory challenges. Regulatory submission and evaluation of chemistry, manufacturing, and controls (CMC) data may be required for changes that have a higher risk to impact product quality. Tabetha Bonacci, PhD.